Breast was taken back from EL and is completely in-house. They learnt from the Smith and Nephew hold on bone filler that has gone nowhere. That mistake predates DW and, as the breast ended partnership shows, they will only go forward with a deal if there’s an out when the partner turns out to be not as committed as the company wants. Partnerships shouldn’t be ruled out but must be entered into with eyes wide open and an out clause to hand.
- Forums
- ASX - By Stock
- Another Opportunity for PolyNovo: Bone Scaffolds
Breast was taken back from EL and is completely in-house. They...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.30 |
Change
0.000(0.00%) |
Mkt cap ! $1.587B |
Open | High | Low | Value | Volume |
$2.34 | $2.35 | $2.27 | $1.711M | 744.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 14000 | $2.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.30 | 13896 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7485 | 2.280 |
5 | 10847 | 2.270 |
5 | 10023 | 2.260 |
12 | 26301 | 2.250 |
11 | 14513 | 2.240 |
Price($) | Vol. | No. |
---|---|---|
2.300 | 8118 | 3 |
2.310 | 9012 | 2 |
2.320 | 2728 | 1 |
2.330 | 14116 | 4 |
2.340 | 7728 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
PNV (ASX) Chart |